Holen Sie sich die Stockscreener-App
12.47
1.30%
0.16
Schlusskurs vom Vortag:
$12.31
Offen:
$12.27
24-Stunden-Volumen:
150.27K
Relative Volume:
0.15
Marktkapitalisierung:
$555.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.86%
1M Leistung:
+19.10%
6M Leistung:
-35.66%
1J Leistung:
+0.00%
1-Tages-Spanne:
$12.03
$12.50
1-Wochen-Bereich:
$11.55
$13.00
52-Wochen-Spanne:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Firmenname
Septerna Inc
Sektor
Branche
Telefon
650-338-3533
Adresse
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Vergleichen Sie SEPN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
12.47 | 520.00M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-02-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-19 | Eingeleitet | TD Cowen | Buy |
| 2024-11-19 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Septerna Inc Aktie (SEPN) Neueste Nachrichten
What drives Septerna Inc. stock priceOver 200% growth - Autocar Professional
Septerna Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - jammulinksnews.com
Is Septerna Inc. a good long term investmentRecord-breaking capital gains - jammulinksnews.com
What analysts say about Septerna Inc. stockBreakthrough financial growth - jammulinksnews.com
What makes Septerna Inc. stock price move sharplyFree Investment Group - Newser
Septerna Insiders Enjoying US$951k Appreciation On US$934.3k Investment - simplywall.st
Why Septerna Inc. stock attracts strong analyst attentionBest Stocks for Capital Safety - Newser
How Septerna Inc. stock performs during market volatilityFast Gains With Reduced Risk - beatles.ru
Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies - MSN
Septerna Announces Collaboration with Novo Nordisk - TipRanks
Septerna, Inc.(NasdaqGM: SEPN) dropped from Russell 3000 Growth Index - MarketScreener
Septerna, Inc.(NasdaqGM: SEPN) dropped from Russell 2500 Growth Index - MarketScreener
The Analyst Verdict: Septerna In The Eyes Of 4 Experts - Nasdaq
Septerna (SEPN) Expected to Announce Earnings on Thursday - Defense World
Septerna, Inc. Holds Virtual Annual Stockholders Meeting - TipRanks
Driehaus Capital Management LLC Increases Stake in Septerna Inc - GuruFocus
Nuveen Asset Management LLC Buys New Stake in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Bank of America Corp DE Makes New Investment in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Kalkine: Septerna Inc Gains Traction on NASDAQ 100 Index from Kalkine - Kalkine Media
Septerna To Present At Jefferies Conference; SEP-631 Phase 1 Trial On Track For Q3 - Nasdaq
Deutsche Bank AG Invests $239,000 in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Septerna to Present at Jefferies Global Healthcare Conference - The Manila Times
GPCR Pioneer Septerna Reveals Latest Drug Discovery Progress at Major Jefferies Healthcare Event - Stock Titan
Jane Street Group LLC Invests $600,000 in Septerna, Inc. (NASDAQ:SEPN) - Defense World
Analysts Think These Stocks Could More Than Double in Value - Investing.com
Analysts Think These Stocks Could More Than Double in Value - MarketBeat
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect? - MSN
Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna - MSN
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled - MSN
Novo Nordisk and US biotech company team up to create obesity pills - Medical Xpress
Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer - The Globe and Mail
Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal - MSN
Cantor Fitzgerald Remains a Buy on Septerna, Inc. (SEPN) - The Globe and Mail
Wells Fargo & Company Boosts Septerna (NASDAQ:SEPN) Price Target to $18.00 - Defense World
Septerna First Quarter 2025 Earnings: US$0.49 loss per share (vs US$6.35 loss in 1Q 2024) - simplywall.st
22,095 Shares in Septerna, Inc. (NASDAQ:SEPN) Bought by The Manufacturers Life Insurance Company - Defense World
Finanzdaten der Septerna Inc-Aktie (SEPN)
Es liegen keine Finanzdaten für Septerna Inc (SEPN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):